For many years AbiogenPharma has been active in the prevention and treatment of hypovitaminosis D, a particularly widespread condition in Italy, not only among the elderly but also in young people.
The primary goal is to demonstrate the remarkable level achieved in formulation development and the manufacturing for those clients who require high quality standards at competitive costs. This activity is complimentary, synergistic and integrated with the Business Development Management of the Company’s Marketing & Sales.
The activities developed and the successes obtained in the last decade confirm the vision of Abiogen Pharma towards a range of services aimed at creating a real value to the projects undertaken and building a synergistic partnership with its customers.
The primary goal is to demonstrate the remarkable level achieved in formulation development and the manufacturing for those clients who require high quality standards at competitive costs. This activity is complimentary, synergistic and integrated with the Business Development Management of the Company’s Marketing & Sales.
The activities developed and the successes obtained in the last decade confirm the vision of Abiogen Pharma towards a range of services aimed at creating a real value to the projects undertaken and building a synergistic partnership with its customers.
For many years AbiogenPharma has been active in the prevention and treatment of hypovitaminosis D, a particularly widespread condition in Italy, not only among the elderly but also in young people.
In the pharmaceutical industry, the cornerstone of the relationship between a Company and a General Practitioner is represented by the organization of the medical-scientific information.Abiogen Pharma interprets this relationship as a continuous service of correct information to the medical profession, and devotes its utmost attention to the training of personnel responsible for medical-scientific information.
Communication
Communication
Abiogen Pharma inherited the results of many years of R&D activities since the late 70’s in the field of osteoarticular metabolism, leading to the discovery of effective drugs for the treatment of bone pathologies: Bisphosphonates.
Abiogen Pharma inherited the results of many years of R&D activities since the late 70’s in the field of osteoarticular metabolism, leading to the discovery of effective drugs for the treatment of bone pathologies: Bisphosphonates.